CD157: A New Prognostic and/or Predictive Marker in Ovarian Cancer? A Retrospective Study

被引：0
|
作者：
Lanzo, G. [1 ]
Borghese, G. [1 ]
Arisio, R. [1 ]
Katsaros, D. [1 ]
Volante, M. [2 ]
Rapa, I. [2 ]
Benedetto, C. [1 ]
Ortolan, E. [3 ]
Funaro, A. [3 ]
机构：
[1] Univ Turin, St Anna Hosp, Dept Obstet & Gynaecol, I-10124 Turin, Italy
[2] Univ Turin, San Luigi Hosp, Dept Pathol, I-10124 Turin, Italy
[3] Univ Turin, Dept Immunogenet, I-10124 Turin, Italy
来源：
REPRODUCTIVE SCIENCES | 2014年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：208A / 209A
页数：2
相关论文
共 50 条
  • [41] Common leukocyte marker CD157 and FLAER allow simple, rapid and sensitive detection of PNH granulocytes and PNH monocytes
    Anliker, M.
    Schauwecker, P.
    Fischer, C.
    Koerper, S.
    Hoechsmann, B.
    Schrezenmeier, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 31 - 31
  • [42] Utility of CD157 as a Common Leukocytes Marker for Paroxysmal Nocturnal Hemoglobinuria Screening in a Single Tube Five Color Combination
    Rahman, Khaliqur
    Gupta, Ruchi
    Harankhedkar, Shivangi
    Gupta, Tanvi
    Sarkar, Manoj K.
    Nityanand, Soniya
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34 (02) : 304 - 309
  • [43] Utility of CD157 as a Common Leukocytes Marker for Paroxysmal Nocturnal Hemoglobinuria Screening in a Single Tube Five Color Combination
    Khaliqur Rahman
    Ruchi Gupta
    Shivangi Harankhedkar
    Tanvi Gupta
    Manoj K. Sarkar
    Soniya Nityanand
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 304 - 309
  • [44] Prognostic and predictive factors in epithelial ovarian cancer
    Boudou-Rouquette, P.
    Pautier, P.
    Morice, P.
    Lhomme, C.
    BULLETIN DU CANCER, 2009, 96 (04) : 425 - 437
  • [45] Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer
    Aggarwal, Sudeepta
    He, Tao
    FitzHugh, William
    Rosenthal, Kim
    Feild, Brian
    Heidbrink, Jenny
    Mesmer, Deborah
    Ruben, Steven M.
    Moore, Paul A.
    GYNECOLOGIC ONCOLOGY, 2009, 115 (03) : 430 - 437
  • [46] A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics
    Staropoli, Nicoletta
    Arbitrio, Mariamena
    Salvino, Angela
    Scionti, Francesca
    Ciliberto, Domenico
    Ingargiola, Rossana
    Labanca, Caterina
    Agapito, Giuseppe
    Iuliano, Eleonora
    Barbieri, Vito
    Cuce, Maria
    Zuccala, Valeria
    Cannataro, Mario
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    BIOMEDICINES, 2022, 10 (05)
  • [47] CD44 as a prognostic and predictive marker for GBM.
    Vaillant, B. D.
    Bhat, K.
    Sulman, E. P.
    Balasubramaniyan, V.
    Wang, S.
    Aldape, K. D.
    Colman, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] Prognostic value of cancer stem cell marker CD133 in ovarian cancer: a meta-analysis
    Zhou, Quan
    Chen, Aihua
    Song, Huamei
    Tao, Jing
    Yang, Huaijie
    Zuo, Manzhen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 3080 - 3088
  • [49] The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis
    Lin, Jiaying
    Ding, Ding
    CANCER CELL INTERNATIONAL, 2017, 17
  • [50] Prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis
    Shi, Y. Y.
    Jiang, H.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (03)
12345